Brickell Biotech DSO Ratio 2011-2025 | BBI

Annual DSO Ratio Brickell Biotech

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	254	135	224	79.2	100	217	44.8	38.1

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
254	38.1	137

Quarterly DSO Ratio Brickell Biotech

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37.8	-	-	1.12 K	3.42 K	170	398	118	144	137	122	98.7	118	75.8	78.9	60.9	82.7	99.3	80.5	79	111	84.6	163	133	271	288	195	84.7	90.3	125	21	148	10.7	349	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.42 K	10.7	266

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	62.6	$ 25.27	-2.43 %	$ 1.22 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	6.01	$ 3.26	-3.12 %	$ 252 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Kamada Ltd. KMDA	103	$ 7.03	0.14 %	$ 260 M	Israel
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 220.27	4.81 %	$ 5 B	Danmark
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Can-Fite BioPharma Ltd. CANF	28.1	$ 0.28	-2.28 %	$ 609 M	Israel
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.3	-3.51 %	$ 7.94 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Anika Therapeutics ANIK	77.3	$ 9.57	0.84 %	$ 140 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	141	$ 12.05	-7.06 %	$ 496 M	USA
Aytu BioScience AYTU	150	$ 2.34	2.59 %	$ 14.7 M	USA
Nymox Pharmaceutical Corporation NYMX	12.5	-	-19.68 %	$ 18.4 M	Canada
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Aptorum Group Limited APM	20.6	$ 1.29	-3.01 %	$ 7.03 M	China
Baudax Bio BXRX	126	-	0.59 %	$ 63 K	USA
Catalyst Biosciences CBIO	3.24	$ 14.01	-8.49 %	$ 922 M	USA
ChromaDex Corporation CDXC	13.2	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	134	$ 566.18	-2.56 %	$ 42.9 B	USA
Cerus Corporation CERS	59.2	$ 2.16	0.47 %	$ 399 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Biogen BIIB	57.9	$ 174.42	1.11 %	$ 25.4 B	USA
Celldex Therapeutics CLDX	86.5	$ 27.36	-2.09 %	$ 1.76 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	169	$ 11.54	0.87 %	$ 746 M	USA